GiantLeap Biotechnology's Convertible Note Round

GiantLeap Biotechnology raised a round of funding on February 09, 2018. Investors include BioExel Medtech Accelerator.

GiantLeap Biotechnology develops tissue engineered neural regeneration products.…

Articles about GiantLeap Biotechnology's Convertible Note Round: